Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $29.2700 (0.86%) ($28.9600 - $29.6400) on Thu. Aug. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 53 | Latest Price | $29.2700(0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO advances 0.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(47%) IWC(44%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.19% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) TLT(-2%) IYT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $28.49(2.74%) | 10 Day Moving Average | $27.94(4.76%) | 20 Day Moving Average | $28.03(4.42%) | To recent high | 0% | To recent low | 28.3% | Market Cap | $4b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |